Serby Michael
Department of Psychiatry, Beth Israel Medical Center, and Albert Einstein College of Medicine, New York, New York 10003, USA.
CNS Spectr. 2003 Aug;8(8):612-3. doi: 10.1017/s1092852900018885.
An 82-year-old man with treatment-resistant depression and early Alzheimer's disease was started on methylphenidate. Significant obsessive-compulsive behavior ensued but diminished over several weeks when methylphenidate was replaced by fluvoxamine. The patient had no prior psychiatric history, but he had a sister with obsessive-compulsive disorder. It appears that methylphenidate precipitated the patient's pathological behavior.
一名患有难治性抑郁症和早期阿尔茨海默病的82岁男性开始服用哌醋甲酯。随后出现了明显的强迫行为,但在哌醋甲酯被氟伏沙明取代后的几周内这种行为有所减轻。该患者既往无精神病史,但他有一个患有强迫症的姐姐。看来哌醋甲酯引发了患者的病态行为。